New weight loss drug may be an effective strategy for preventing or treating high blood pressure

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.

Aptose Biosciences secures funds for AML treatment development

Tuspetinib is being analysed for the treatment of acute myeloid leukaemia. Credit: Yomal2233/Shutterstock. Aptose Biosciences has secured a loan of $10m through a facility agreement

September 2, 2024

Untreated, New-Onset Hypertension Tied to Fibroid Development in Midlife

NEW ORLEANS — Among midlife women, untreated and new-onset hypertension were associated with an increased risk of developing fibroids, while treated hypertension was linked to

October 21, 2023

Astellas and Cullgen to develop small molecule protein degraders – Pharmaceutical Technology

Astellas Pharma is a Japanese multinational pharmaceutical company. Credit: JHVEPhoto via Shutterstock. Japan-based Astellas Pharma has entered a partnership with Cullgen to discover and develop

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.